Visceral leishmaniasis: immunology and prospects for a vaccine

被引：78
|
作者：
Kaye, P. M. [1 ,2 ]
Aebischer, T. [3 ]
机构：
[1] Univ York, Ctr Immunol & Infect, Hull York Med Sch, York YO10 5YW, N Yorkshire, England
[2] Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England
[3] Robert Koch Inst, D-13353 Berlin, Germany
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2011年 / 17卷 / 10期
关键词：
Immunology; vaccine; visceral leishmaniasis; TRANSMISSION-BLOCKING VACCINE; T-CELLS; CUTANEOUS LEISHMANIASIS; DONOVANI INFECTION; MAJOR INFECTION; MEGLUMINE ANTIMONIATE; CANINE LEISHMANIASIS; ANTIGEN PRESENTATION; PROTECTIVE IMMUNITY; EXPRESSION CLONING;
D O I：
10.1111/j.1469-0691.2011.03610.x
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Human visceral leishmaniasis (HVL) is the most severe clinical form of a spectrum of neglected tropical diseases caused by protozoan parasites of the genus Leishmania. Caused mainly by L. donovani and L. infantum/chagasi, HVL accounts for more than 50 000 deaths every year. Drug therapy is available but costly, and resistance against several drug classes has evolved. Here, we review our current understanding of the immunology of HVL and approaches to and the status of vaccine development against this disease.
引用
收藏
页码：1462 / 1470
页数：9
相关论文
共 50 条
  • [1] Vaccine prospects of killed but metabolically active Leishmania against visceral leishmaniasis
    Das, Amrita
    Ali, Nahid
    [J]. EXPERT REVIEW OF VACCINES, 2012, 11 (07) : 783 - 785
  • [2] Diagnostic prospects for visceral leishmaniasis
    Rabello, Ana
    de Sousa-Gomes, Marcia Leite
    [J]. REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2010, 43 : 74 - 76
  • [3] Prospects for visceral leishmaniasis control in Amazonian municipalities
    Garcez, Lourdes Maria
    Chagas, Anadeiva Portela
    Fonseca Gomes, Patrick Abdala
    Cardoso, Joyce Favacho
    Correia Miranda, Jefferson Francisco
    Jeronimo Dickson, Luis Antonio
    Mota, Eduardo Ferreira
    Bezerra, Lucilandia Maria
    Fraiha Neto, Habib
    Quinnell, Rupert Julian
    Courtenay, Orin
    [J]. REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2008, 41 : 95 - 96
  • [4] Immunology of Helicobacter pylori and prospects for vaccine
    Blanchard, TG
    Czinn, SJ
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2000, 29 (03) : 671 - +
  • [5] CUTANEOUS LEISHMANIASIS - THE PROSPECTS FOR A KILLED VACCINE
    GREENBLATT, CL
    [J]. PARASITOLOGY TODAY, 1988, 4 (02): : 53 - 54
  • [6] The challenges on developing vaccine against visceral leishmaniasis
    Bezerra Jeronimo, Selma Maria
    Pearson, Richard D.
    [J]. REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2016, 49 (04) : 395 - 397
  • [7] Visceral leishmaniasis: An overview of vaccine adjuvants and their applications
    Ratnapriya, Sneha
    Keerti
    Sahasrabuddhe, Amogh A.
    Dube, Anuradha
    [J]. VACCINE, 2019, 37 (27) : 3505 - 3519
  • [8] Animal models for vaccine studies for visceral leishmaniasis
    Garg, Ravendra
    Dube, Anuradha
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2006, 123 (03) : 439 - 454
  • [9] Recent developments and future prospects in the treatment of visceral leishmaniasis
    Sundar, Shyam
    Singh, Anup
    [J]. THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2016, 3 (3-4) : 98 - 109
  • [10] The epidemiology of visceral leishmaniasis in Bangladesh: prospects for improved control
    Bern, Caryn
    Chowdhury, Rajib
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2006, 123 (03) : 275 - 288
12345